MIRIAM ALBRITTON: Open Payments
NPI 1336659622 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$861 in 51 payments from 10 companies in 2025. Trend: 2023 $496 · 2024 $660 · 2025 $861
Food & beverage: $861
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $269 |
| Novo Nordisk Inc | 8 | $201 |
| Amgen Inc. | 12 | $135 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $50 |
| SI-BONE, INC. | 1 | $48 |
| PFIZER INC. | 2 | $42 |
| Lilly USA, LLC | 2 | $38 |
| Inspire Medical Systems, Inc. | 1 | $35 |
| Exact Sciences Corporation | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
Products named: UBRELVY, QULIPTA, OTEZLA, JARDIANCE, Wegovy, NURTEC ODT, INSPIRE, REPATHA.
Industry payments across FL — which companies pay providers there.
